$1B Deal On Zyprexa Still May Not End Lilly's Woes
Even if Eli Lilly and Co. agrees to a $1 billion settlement to rid itself of federal and state investigations into the handling of anti-psychotic drug Zyprexa, it will still be...To view the full article, register now.
Already a subscriber? Click here to view full article